Tags

Type your tag names separated by a space and hit enter

Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients.
Am J Hypertens. 2006 Oct; 19(10):998-1004.AJ

Abstract

BACKGROUND

Impaired fasting glucose (IFG) and renal dysfunction are recognized as independent risk factors for adverse heart outcomes. This study examines the interaction of renal dysfunction and IFG (>or=110 mg/dL) upon the risk of ischemic heart disease (IHD) mortality among treated hypertensive subjects.

METHODS

Subjects were 9918 participants in a worksite-based antihypertensive treatment program in New York City (1981 to 1999) with baseline estimated glomerular filtration rate (GFR) >30 mL/min/1.73 m2 (estimated by Cockcroft and Gault formula) observed for a mean follow-up of 9.6 +/- 5.0 years (range 0.5-20.0 years). Outcome events were IHD deaths (n = 337) ascertained from the National Death Index. Cox proportional hazard models were constructed for the entire cohort to assess the interaction and then stratified by moderate renal dysfunction (MRD; GFR 60-30 mL/min/1.73 m2). Age and sex adjusted rates were calculated within MRD and NKF-defined categories. Hazard ratios for IFG were calculated within MRD strata.

RESULTS

The interaction product term of MRD and IFG significantly improved (P = .001) a Cox proportional hazard model after adjusting for known cardiovascular risk factors. Among participants with GFR >or=60 mL/min/1.73 m2 the IHD mortality hazard ratio for IFG was 1.47 (95% CI = 1.09-1.99; P = .012). Conversely, among participants with MRD, the IHD mortality hazard ratio for IFG was 0.44 (95% CI = 0.21-0.94; P = .034).

CONCLUSIONS

These results suggest an attenuating effect modification of GFR on IHD mortality risk associated with IFG among treated hypertensive subjects. Whether the observed qualitative interaction is simply statistical or reflects a biological counter-regulatory mechanism requires additional study.

Authors+Show Affiliations

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York 10461, USA. shailper@aecom.yu.eduNo affiliation info availableNo affiliation info available

Pub Type(s)

Evaluation Study
Journal Article

Language

eng

PubMed ID

17027817

Citation

Hailpern, Susan M., et al. "Renal Dysfunction Predicts Attenuation of Ischemic Heart Disease Mortality Risk From Elevated Glucose Among Treated Hypertensive Patients." American Journal of Hypertension, vol. 19, no. 10, 2006, pp. 998-1004.
Hailpern SM, Cohen HW, Alderman MH. Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients. Am J Hypertens. 2006;19(10):998-1004.
Hailpern, S. M., Cohen, H. W., & Alderman, M. H. (2006). Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients. American Journal of Hypertension, 19(10), 998-1004.
Hailpern SM, Cohen HW, Alderman MH. Renal Dysfunction Predicts Attenuation of Ischemic Heart Disease Mortality Risk From Elevated Glucose Among Treated Hypertensive Patients. Am J Hypertens. 2006;19(10):998-1004. PubMed PMID: 17027817.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients. AU - Hailpern,Susan M, AU - Cohen,Hillel W, AU - Alderman,Michael H, PY - 2006/01/23/received PY - 2006/02/23/revised PY - 2006/03/11/accepted PY - 2006/10/10/pubmed PY - 2006/12/9/medline PY - 2006/10/10/entrez SP - 998 EP - 1004 JF - American journal of hypertension JO - Am J Hypertens VL - 19 IS - 10 N2 - BACKGROUND: Impaired fasting glucose (IFG) and renal dysfunction are recognized as independent risk factors for adverse heart outcomes. This study examines the interaction of renal dysfunction and IFG (>or=110 mg/dL) upon the risk of ischemic heart disease (IHD) mortality among treated hypertensive subjects. METHODS: Subjects were 9918 participants in a worksite-based antihypertensive treatment program in New York City (1981 to 1999) with baseline estimated glomerular filtration rate (GFR) >30 mL/min/1.73 m2 (estimated by Cockcroft and Gault formula) observed for a mean follow-up of 9.6 +/- 5.0 years (range 0.5-20.0 years). Outcome events were IHD deaths (n = 337) ascertained from the National Death Index. Cox proportional hazard models were constructed for the entire cohort to assess the interaction and then stratified by moderate renal dysfunction (MRD; GFR 60-30 mL/min/1.73 m2). Age and sex adjusted rates were calculated within MRD and NKF-defined categories. Hazard ratios for IFG were calculated within MRD strata. RESULTS: The interaction product term of MRD and IFG significantly improved (P = .001) a Cox proportional hazard model after adjusting for known cardiovascular risk factors. Among participants with GFR >or=60 mL/min/1.73 m2 the IHD mortality hazard ratio for IFG was 1.47 (95% CI = 1.09-1.99; P = .012). Conversely, among participants with MRD, the IHD mortality hazard ratio for IFG was 0.44 (95% CI = 0.21-0.94; P = .034). CONCLUSIONS: These results suggest an attenuating effect modification of GFR on IHD mortality risk associated with IFG among treated hypertensive subjects. Whether the observed qualitative interaction is simply statistical or reflects a biological counter-regulatory mechanism requires additional study. SN - 0895-7061 UR - https://www.unboundmedicine.com/medline/citation/17027817/Renal_dysfunction_predicts_attenuation_of_ischemic_heart_disease_mortality_risk_from_elevated_glucose_among_treated_hypertensive_patients_ L2 - https://academic.oup.com/ajh/article-lookup/doi/10.1016/j.amjhyper.2006.03.010 DB - PRIME DP - Unbound Medicine ER -